Skip to main content

Quantifying circulating cell-free DNA in humans.

Meddeb R, Dache ZAA, Thezenas S, Otandault A, Tanos R, Pastor B, Sanchez C, Azzi J, Tousch G, Azan S, Mollevi C, Adenis A, El Messaoudi S, Blache P, Thierry AR

Publication: Sci Rep (2019) • Vol 9 • Page 5220PMID: 30914716View on PubMed

Purpose

This paper compared levels of nuclear and mitochondrial cell-free DNA (cfDNA) between specimens from patients < or ≥47 years of age, males and females, and healthy patients and those with metastatic colorectal carcinoma (CRC) and among blood specimens collected into Streck BCT tube and K2EDTA tubes at different times of day and after delayed centrifugation.

Conclusion

Healthy individuals and CRC patients had much fewer copies of mitochondrial cfDNA per mL of plasma than nuclear cfDNA but had a higher concentration (ng/mL of plasma) of nuclear cfDNA than mitochondrial cfDNA.  Copies of nuclear cfDNA per mL of plasma were higher in plasma from healthy patients ≥47 years compared to those <47 years, and in plasma from healthy males relative to healthy females. However, the number of copies of mitochondrial cfDNA per mL of plasma   was comparable between the age groups and genders in healthy patients.  Plasma from patients with CRC had a higher median number of copies of nuclear cfDNA per mL of plasma and a lower median number of copies of mitochondrial cfDNA per mL of plasma than plasma from healthy patients, resulting in a 20-fold higher ratio of mitochondrial to nuclear cfDNA copies per mL of plasma among healthy patients compared to those with CRC. Nuclear cfDNA levels in plasma were comparable among immediately processed specimens and blood in Streck BCT tubes that was subjected to centrifugation delays ≤ 7 days, but nuclear and mitochondrial cfDNA levels increased 2- and 12-fold, respectively, when blood was stored in EDTA tubes for 2 days.  In both tube types, nuclear cfDNA levels were highest in specimens collected after fasting (9 AM) and lowest when specimens were collected mid-day (Noon); however, mitochondrial cfDNA levels were not affected by time of day of blood collection. 

Studies (1)

Purpose

This study compared levels of nuclear and mitochondrial cfDNA between specimens from patients < or ≥47 years of age, males and females, and healthy patients and those with metastatic colorectal carcinoma (CRC) and among blood specimens collected into Streck BCT tube and K2EDTA tubes at different times of day or subjected to centrifugation delays. Blood was collected from 104 heathy patients and 118 patients with metastatic colorectal cancer (CRC). Plasma was obtained by centrifugation at 1,200 g for 10 min at 4°C followed by 1,600 g for 10 min at 4°C within 2 h of blood collection, unless otherwise specified. cfDNA was isolated using the Qiagen Blood Mini kit and stored at -20°C until analysis.  Nuclear and mitochondrial cell-free DNA were quantified by real-time PCR amplification of wildtype KRAS and Cytochrome oxidase III genes, respectively.  To identify the effect of delayed centrifugation, blood from each of 7 healthy donors was collected into four Cell-Free DNA BCT STRECK tubes and three K2EDTA tubes and stored for 0, 2, 5 and 7 (BCT only) days at room temperature before centrifugation. To investigate the effect of time of day of blood collection, blood was collected from four healthy donors (2 male, 2 female) at 9 AM (fasted), 12 PM (2 h after breakfast), 3 PM (2 h after lunch), and 6 PM (4 h after lunch) into a Cell-Free DNA BCT Streck tube and a K2EDTA tube.

Summary of Findings

Healthy individuals and CRC patients both had much fewer copies of mitochondrial cfDNA per mL of plasma than nuclear cfDNA (P<0.0001, both), but had a higher concentration (ng/mL of plasma) of nuclear cfDNA than mitochondrial cfDNA (P<0.0001, both). A greater number of  copies of nuclear cfDNA per mL of plasma were present in plasma from healthy patients that were  ≥47 years of age  than those <47 years (1.73 × 103 versus 1.36 × 103 copies/mL) and in plasma from males than females (1.69 × 103 versus 1.48 × 103 copies/ml, P=0.048). However, the number of copies of mitochondrial cfDNA per mL of plasma were comparable among the different age groups and genders of healthy patients.  Mulltivariate analysis revealed that age, specifically > 47 years, was predictive of a higher number of nuclear cfDNA copies per mL of plasma compared to younger patients (odds ratio, OR=2.41, P=0.033). Plasma from patients with CRC had a higher median number of nuclear cfDNA copies per mL of plasma and a lower median number of mitochondrial cfDNA copies per mL than plasma from healthy patients (4.73 × 103 versus 1.64 × 103 copies/ml, P<0.0001 and 1.44 × 107 versus 8.32 × 107 copies/mL, P<0.0001, respectively). Plasma from patients with CRC had a higher median number of copies of nuclear cfDNA per mL of plasma and a lower median number of copies of mitochondrial cfDNA per mL of plasma than plasma from healthy patients (4.73 × 103 versus 1.64 × 103 copies/ml, P<0.0001 and 1.44 × 107 versus 8.32 × 107 copies/mL, P<0.0001, respectively), resulting in a 20-fold higher ratio of mitochondrial to nuclear cfDNA copies per mL of plasma among healthy patients compared to those with CRC (P<0.0001). Nuclear cfDNA levels in plasma were comparable among immediately processed specimens and blood in Streck BCT tubes that was subjected to centrifugation delays ≤ 7 days, but nuclear and mitochondrial cfDNA levels increased 2- and 12-fold, respectively, when blood was stored in EDTA tubes for 2 days.  In both tube types, nuclear cfDNA levels were highest in specimens collected after fasting (9 AM) and lowest when specimens were collected mid-day (Noon); however, mitochondrial cfDNA levels were not affected by time of day of blood collection.

  • Biospecimens

    FluidBlood
    FluidPlasma
  • Preservation Types

    FrozenStreck/BCTNone (Fresh)
  • Diagnoses

    Not specified
    NeoplasticCarcinoma
  • Platforms

    DNAReal-time qPCR
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    PreaquisitionDiagnosis/ patient condition
    Healthy
    Metastatic CRC
    PreaquisitionPatient age
    < 47 years
    ≥ 47 years
    PreaquisitionPatient gender
    Female
    Male
    Biospecimen AcquisitionTime of biospecimen collection
    12 PM (2 h after breakfast)
    3 PM (2 h after lunch)
    6 PM (4 h after lunch)
    9 AM (fasted)
    Biospecimen AcquisitionType of collection container/solution
    K2EDTA tube
    Streck DNA BCT
    Biospecimen Aliquots and ComponentsCentrifugation
    Centrifugation delays investigated
    StorageTime at room temperature
    0 days
    2 days
    5 days
    7 days